10x Genomics, Inc. splits its revenue into 8 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Chromium Consumables at $363.2 million, 57% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
|---|---|---|---|---|---|---|---|---|
| Revenue |
617
|
643
|
611
|
619
|
516
|
490
|
299
|
246
|
| Chromium Consumables |
371
+1.8%
share 60.1%
|
363
-2.4%
share 56.5%
|
372
-11.4%
share 61.0%
|
420
+5.0%
share 67.9%
|
400
+2.4%
share 77.5%
|
391
share 79.7%
|
—
|
—
|
| Consumables |
—
|
—
|
—
|
—
|
—
|
—
|
253
+22.1%
share 84.6%
|
207
share 84.1%
|
| Spatial Consumables |
160
+19.9%
share 25.9%
|
144
+18.9%
share 22.4%
|
121
+104.5%
share 19.8%
|
59
+68.5%
share 9.6%
|
35
+26.2%
share 6.8%
|
28
share 5.7%
|
—
|
—
|
| Instruments |
—
|
—
|
—
|
—
|
—
|
64
+60.7%
share 13.1%
|
40
+14.8%
share 13.4%
|
35
share 14.2%
|
| Licensing And Royalty Revenue |
4
-90.6%
share 0.7%
|
46
+14272.3%
share 7.2%
|
0
share 0.1%
|
—
|
—
|
—
|
—
|
—
|
| Spatial Instruments |
27
-36.4%
share 4.4%
|
34
-40.7%
share 5.3%
|
58
share 9.4%
|
—
|
14
+4469.0%
share 2.7%
|
0
share 0.1%
|
—
|
—
|
| Services |
36
+22.6%
share 5.9%
|
33
+34.6%
share 5.1%
|
24
+54.9%
share 4.0%
|
16
+86.4%
share 2.5%
|
8
+15.8%
share 1.6%
|
7
+20.6%
share 1.5%
|
6
+48.2%
share 2.0%
|
4
share 1.7%
|
| Chromium Instruments |
19
-36.0%
share 3.1%
|
23
-35.6%
share 3.5%
|
35
-26.4%
share 5.8%
|
48
-18.3%
share 7.7%
|
59
share 11.3%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- TXG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Pleasanton, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1770787
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.